Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

Max Healthcare acquires 64% stake in India’s Jaypee Healthcare for $20 billion

This acquisition includes a 500-bed facility, strengthening Max Healthcare's position among the top 5 for-profit hospitals in the country. Max Healthcare Institute Ltd, a New Delhi-based for-profit hospital chain, has partnered with the Lakshdeep Group to acquire a 64% stake in Jaypee Healthcare Ltd (JHL) for ₹1,660 crore ($20 billion). Lakshdeep Group, currently undergoing Corporate […]
September 18, 2024

Aedifica buys four “futureproof” UK care homes

Belgian pan-European healthcare real estate investor Aedifica has bought four new UK care homes for a total of £61.5 million (~€73 million). Aedifica describes the homes as “futureproof” due to being highly energy efficient.
September 13, 2024

Bupa UK launches GP subscription service for £200 per year

The UK branch of British multinational healthcare company Bupa is launching a new direct-to-consumer subscription service for primary care, giving customers access to same-day appointments with a private GP, starting at just over £200 per year.
September 6, 2024

Remote patient monitoring can cut chronic disease care costs by 40% — an interview with Lasse Rousi, Medixine 

Over the coming years and decades an increasing amount of care will be delivered to patients in their homes. New devices and wearables that can collect health data from people whilst they’re at home and healthcare’s digitalisation trend are opening up new possibilities, both for prevention and for providing better and more efficient care to those with chronic conditions. 
September 5, 2024

Mubadala and CBC Group acquire Belgian biopharma UCB’s China operations

UCB, a Belgian biopharma company, plans to divest its business in China, to CBC Group, a Singapore-based investment firm, and Mubadala, a global investment company from Abu Dhabi, for $680 million.  The deal, pending regulatory approval, is expected to close in Q4 2024 and includes UCB’s neurology and allergy portfolios, as well as its manufacturing site in Zhuhai, China.
August 29, 2024

UK launches £400 million public-private partnership to address critical need in pharmaceutical testing

The UK’s Department of Health and Social Care (DHSC), NHS England, and the Association of the British Pharmaceutical Industry (ABPI) have launched a £400 million initiative to improve the country’s pharmaceutical testing capabilities. Termed the ‘Voluntary Scheme for Branded Medicine Pricing, Access and Growth’ (VPAG), this public-private investment will create up to 18 new clinical trial hubs across the UK, speeding up the development and availability of new medicines, as detailed in the August 28 press release.
August 29, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us